Clinical trials
Observational Heart Diseases trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 6 |
| Unknown status | 6 |
| Active, not recruiting | 4 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boston Scientific Corporation | 2 |
| University of Edinburgh | 2 |
| University of Leeds | 2 |
| University of Oxford | 2 |
| Abbott Medical Devices | 1 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Biotronik SE & Co. KG | 1 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| Creavo Medical Technologies Ltd | 1 |
| ECRI bv | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Diseases | 30 |
| Cardiovascular Diseases | 14 |
| Atrial Fibrillation | 4 |
| Diabetes Mellitus | 4 |
| Heart Failure | 4 |
| Renal Insufficiency, Chronic | 4 |
| Arrhythmias, Cardiac | 3 |
| Cardiomyopathies | 3 |
| Acquired Immunodeficiency Syndrome | 2 |
| Arthritis | 2 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.